Table 2.
The relationship between NCAPG clinicopathologic characteristic in the glioma.
| Characteristics | Total(N) | Odds Ratio (OR) | P value |
|---|---|---|---|
| WHO grade (G3 vs. G2) | 467 | 5.467 (3.696-8.173) | <0.001 |
| 1p/19q codeletion (non-codel vs. codel) | 528 | 1.658 (1.148-2.402) | 0.007 |
| Primary therapy outcome (PR&CR vs. PD&SD) | 458 | 0.488 (0.335-0.709) | <0.001 |
| IDH status (Mut vs. WT) | 525 | 0.317 (0.193-0.508) | <0.001 |
| Gender (Male vs. Female) | 528 | 1.183 (0.840-1.669) | 0.336 |
| Race (White vs. Black or African American) | 509 | 0.707 (0.287-1.669) | 0.433 |
| Age (>40 vs. <=40) | 528 | 1.628 (1.155-2.299) | 0.005 |
| Histological type (Oligodendroglioma vs. Astrocytoma) | 394 | 0.799 (0.538-1.187) | 0.267 |
| Laterality (Right vs. Left) | 517 | 0.962 (0.681-1.358) | 0.825 |